Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Most relevant
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about ASTRAZENECA PLC
08:05aASTRAZENECA : A Sense of Comfort, Providing Housing to Patients and their Families During ..
AQ
07:12aASTRAZENECA : Science Committee appointment (Form 6-K)
PU
06:52aASTRAZENECA : establishes new Sustainability Committee of the Board (Form 6-K)
PU
06:29aANALYST RECOMMENDATIONS : Amgen, Apple, AstraZeneca, FedEx, T-Mobile US...
06:06aASTRAZENECA : Coronavirus - 40,000 Vaccines Administered in Private Pharmacies
AQ
05:41aASTRAZENECA : Covid to be like the common cold - one day, says vaccine co-designer
AQ
04:10aASTRAZENECA : Credit Suisse reiterates its Buy rating
MD
03:27aASTRAZENECA : Takes Stake In UK's VaxEquity Under Long-Term Partnership
MT
02:21aASTRAZENECA : invests in Imperial's self-amplifying RNA technology with eye on future drug..
RE
02:12aASTRAZENECA : to discover and develop self-amplifying RNA therapeutics in new collaboratio..
PU
02:00aVaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Ampl..
CI
02:00aAstraZeneca PLC Appoints Diana Layfield as Member of the Science Committee, with Effect..
CI
02:00aAstraZeneca PLC Announces Board Appointments
CI
09/22ASTRAZENECA : Japan doubles COVID-19 vaccine donation pledge to 60 mln doses
RE
09/22ASTRAZENECA : Brazil regulator says adolescent death unrelated to Pfizer shot
RE
09/22MODERNA : Canada paused COVID-19 vaccine deliveries as supply far exceeds demand
AQ
09/22ASTRAZENECA : Anger, confusion spread over UK's new COVID travel rules
AQ
09/22PFIZER : COVID-19 Vaccine Elicits Strong Immune Response As Second Dose, Thailand Study Sa..
MT
09/22SINOVAC BIOTECH : Thailand delays plan to re-open cities to tourists until November
RE
09/22India's Serum Institute to invest $68 mln in UK vaccine maker Oxford Biomedica
RE
09/22ASTRAZENECA : MEDIA-UK govt approves Covishield as qualified vaccine for travel - Mint
RE
09/22OXFORD BIOMEDICA : Swings to H1 Profit on Revenue from COVID-19 Vaccine Manufacturing
MT
09/22ASTRAZENECA : India likely to allow smaller gap between AstraZeneca COVID vaccine doses so..
RE
09/21Shangula Rages Against West's Vaccine Nationalism
AQ
09/21ASTRAZENECA : India calls new UK COVID-19 vaccine rules 'discriminatory'
AQ
09/21ASTRAZENECA : Investment will transform development and commercialisation of new medicines..
PU
09/21EUROPEAN MIDDAY BRIEFING : Stocks Rebound But -2-
DJ
09/21ASTRAZENECA : to Invest $360 Million in New Irish Manufacturing Facility
MT
09/21FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps
RE
09/21EQS-NEWS : Capital.com Announces Top Hire to Drive Growth in Asia
DJ
09/21AstraZeneca to invest $360 million in Irish drug manufacturing site
RE
09/21ASTRAZENECA : Plans New $360 Million Irish Manufacturing Site
MT
09/21ASTRAZENECA : to invest $360m in advanced manufacturing facility in Ireland
PU
09/21AstraZeneca PLC to Invest $360 Million in Advanced Manufacturing Facility in Ireland
CI
09/21AstraZeneca to Build $360 Million Manufacturing Plant in Dublin
DJ
09/21EMEA MORNING BRIEFING : Stocks to Rebound as -2-
DJ
09/20Healthcare Shares Fall Amid Concerns About Delta Variant -- Healthcare Roundup
DJ
09/20THE LATEST : EU official: US isn't being loyal or transparent
AQ
09/20ADRs Close Lower, AstraZeneca Rises
DJ
09/20ASTRAZENECA : White House plan to allow foreign visitors silent on easing Canada-U.S. rest..
AQ
09/20European ADRs Move Sharply Lower in Monday Trading
MT
09/20DAIICHI SANKYO : Enhertu reduced the risk of disease progression or death by 72% vs. trast..
AQ
09/20ASTRAZENECA : Imfinzi plus chemotherapy tripled patient survival at three years in the CAS..
AQ
09/20DAIICHI SANKYO : Enhertu demonstrated robust and durable tumour response of 54.9% in patie..
AQ
09/20ASTRAZENECA : SVB Leerink Adjusts AstraZeneca's PT to $71 from $69, Keeps Outperform Ratin..
MT
09/20GRITSTONE BIO : Oncology Doses First Volunteer in Phase 1 Trial of COVID-19 Vaccine Booste..
MT
09/20ASTRAZENECA : Credit Suisse remains its Buy rating
MD
09/20ASTRAZENECA : Buy rating from JP Morgan
MD
09/20ASTRAZENECA : Egypt Receives More Than 564k Doses of Covid-19 Vaccine Astrazeneca From Fra..
AQ
09/20FTSE Drops, AstraZeneca Rises on Upbeat Breast Cancer Data
DJ
09/20ASTRAZENECA : Ground-breaking Phase III head-to-head DESTINY-Breast03 results featured at ..
PU
09/20ASTRAZENECA : Says Imfinzi Immunotherapy Combos Delivered Overall Survival Benefit at Thre..
MT
09/20ASTRAZENECA : Touts Positive Survival Data for Cancer Therapies Imfinzi, Enhertu
MT
09/20DAIICHI SANKYO : Enhertu demonstrated clinically meaningful and durable response in patien..
AQ
09/20ASTRAZENECA : Imfinzi combined with novel immunotherapies improved clinical outcomes for p..
AQ
09/20UK Energy Retail Market Crisis Threatens Smaller Suppliers
DJ
09/20Astrazeneca plc and Daiichi Sankyo Company, Limited Announces Results of HER2-Positive ..
CI
09/20AstraZeneca's Enhertu Cancer Treatment Reduced Risk of Disease Progression by 72%
DJ
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Reduces Breast Cancer Death In Late-Stage Study
MT
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Shows 55% Tumor Response Rate in Lung Cancer Patien..
MT
09/20ASTRAZENECA : Lung Cancer Combination Treatments Improve Objective Response Rate
MT
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Prolongs Survival in Mid-Stage Gastric Cancer Study
MT
09/20ASTRAZENECA : Imfinzi Combo Triples Survival for Small-Cell Lung Cancer Patients
MT
09/19Daiichi Sankyo Company, Limited Announces Datopotamab Deruxtecan Shows Encouraging Tumo..
CI
09/18ASTRAZENECA : IMFINZI plus chemotherapy tripled patient survival at three years in the CAS..
BU
09/18AstraZeneca PLC Provides Updated Results of Imfinzi Plus Chemotherapy Tripled Patient S..
CI
09/18ASTRAZENECA : Enhertu reduced the risk of disease progression or death by 72% vs. trastuzu..
PU
09/18ASTRAZENECA : ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease progr..
BU
09/18Daiichi Sankyo, Inc. and AstraZeneca PLC Announces Results of Destiny-Breast03 Phase II..
CI
09/18ASTRAZENECA : Enhertu demonstrated robust and durable tumour response of 54.9% in patients..
PU
09/18ASTRAZENECA : ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated robust and durable t..
BU
09/17The case for, and against, COVID-19 vaccine boosters
RE
09/17ASTRAZENECA : Enhertu demonstrated clinically meaningful and durable response in patients ..
PU
09/17ASTRAZENECA : ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningfu..
BU
09/17AstraZeneca and Daiichi Sankyo Company, Limited Announce ENHERTU® (fam-trastuzumab deru..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ASTRAZENECA PLC